SCHEMBL5873862

SCHEMBL5873862

CCOP(=O)(OCC)OCc1ccc(NC=C2C(=O)Nc3ncc(-c4ccccc4)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 1/20 0.36
MAP3K11 Q16584 2/20 0.35
NTRK1 P04629 2/20 0.33
CHEK1 O14757 1/20 0.32
AURKA O14965 1/20 0.32
DAPK3 O43293 1/20 0.32
PRKD3 O94806 1/20 0.32
MAP4K4 O95819 1/20 0.32
ABL1 P00519 1/20 0.32
CSF1R P07333 1/20 0.32
RET P07949 1/20 0.32
MET P08581 1/20 0.32
PDGFRB P09619 1/20 0.32
PIM1 P11309 1/20 0.32
FGFR1 P11362 1/20 0.32
PDGFRA P16234 1/20 0.32
FLT1 P17948 1/20 0.32
LTK P29376 1/20 0.32
GRK5 P34947 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6872582 0.89 CDK9 (0.40) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL6872584 0.89 CDK9 (0.40) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL5873793 0.82 JAK3 (0.39) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL5873796 0.82 JAK3 (0.39) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL7728583 0.78 JAK3 (0.36) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL5873915 0.78 JAK3 (0.43) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL5873916 0.78 JAK3 (0.43) JAK3MAP3K11NTRK1CHEK1AURKA
SCHEMBL5873838 0.77 PTK2 (0.35) JAK3MAP3K11METCDK9
SCHEMBL5873840 0.77 PTK2 (0.35) JAK3MAP3K11METCDK9
SCHEMBL5873883 0.76 CCNT1 (0.35) JAK3MAP3K11RETCDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129253-B2 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-10-31 US disclosed
US-20040191210-A1 Compounds GLENNON KIMBERLEY CAROLINE (US) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040191210-A1 Compounds CDK1, AKT1, RPS6KA1 JAK3 439/4885MAP3K11 75/4885NTRK1 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.